A detailed history of Nantahala Capital Management, LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 790,936 shares of COGT stock, worth $7.18 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
790,936
Previous 790,936 -0.0%
Holding current value
$7.18 Million
Previous $6.67 Million 28.12%
% of portfolio
0.51%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.38 - $9.02 $657,000 - $1.35 Million
150,000 Added 23.4%
790,936 $5.32 Million
Q4 2023

Feb 14, 2024

BUY
$4.06 - $10.08 $267,700 - $664,634
65,936 Added 11.47%
640,936 $3.77 Million
Q3 2023

Nov 14, 2023

BUY
$9.69 - $13.34 $4.95 Million - $6.81 Million
510,868 Added 796.59%
575,000 $5.61 Million
Q2 2023

Aug 14, 2023

BUY
$9.85 - $13.24 $631,700 - $849,107
64,132 New
64,132 $759,000

Others Institutions Holding COGT

About Cogent Biosciences, Inc.


  • Ticker COGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,758,300
  • Market Cap $597M
  • Description
  • Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...
More about COGT
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.